Genomic absence of the gene encoding T cell receptor Vβ7.2 is linked to the presence of autoantibodies in Sjögren's syndrome

Open Access
Publisher Website
Google Scholar
Abstract
Objective: It is not yet known whether the absence of certain T cell receptor Vβ (TCRBV) genes (e.g., due to genomic deletion) has functional significance. We examined this question in relation to a known 21.6‐kb insertion/deletion‐related polymorphism (IDRP) in the human BV locus.Methods: New polymerase chain reaction (PCR) genotyping methods were used. Monoclonal antibodies to TCRBV gene products were used to confirm the absence of the relevant proteins. Patients with Sjögren's syndrome (SS) or systemic lupus erythematosus (SLE) were compared with normal controls with regard to TCR genotypes and serologic profiles.Results: There are 3 known haplotypes (I, D1, D2) and 6 possible genotypes related to the 21.6‐kb IDRP. Novel PCR‐based methods were used to define these genotypes. In subjects with deleted/deleted (D/D) genotypes, T cells could not express Vβ7.2 TCRs, as assayed with a new antibody specific for Vβ7.2. This was the sole significant difference between subjects without the insertion and those with either 1 or 2 copies. Surprisingly, we found that the D/D genotype was associated with primary SS, but only when pathogenic autoantibodies were present.Conclusion: These results suggest that T cells expressing TCRs with Vβ7.2 are protective against a pathogenic immune response in SS. Thus, genomic polymorphism of TCR genes (along with the correct HLA alleles) determines whether T cells can direct a pathogenic autoimmune response.

This publication has 61 references indexed in Scilit: